Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 

Click here to go back to your search results.

Liver Cancer treatment details. National Taiwan University Hospital, Taipei, Taiwan Region



Survival: 10.7 months
   
Toxicity Grade: 4
   
Treatments:
   
Drugs:
Country: Taiwan Region
   
City/State/Province: Taipei
   
Hospital: National Taiwan University Hospital
   
Journal: Link
   
Date: 7/2013

Description:
Patients:
This phase 2 study involved 51 advanced hepatocellular carcinoma patients who had no prior treatment. The median patient age was 58 years and 86% were male.

Treatment:
Patients were treated with the biologic therapy agents bevacizumab and erlotinib.

Toxicities:
The most severe toxicity was grade 4 gastrointestinal bleeding. Grade 3 rash, acne, and diarrhea were also reported.

Results:
The median overall survival was 10.7 months.

Support:
This study was partially supported by the pharmaceutical company Hoffmann La Roche.

Correspondence: Dr. Ann-Lii Cheng; email: alcheng@ntu.edu.tw

E-mail to a Friend Email Physician More Information